Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–19 of 19 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Gastric Varices Clear all

Conditions: Esophageal and Gastric Varices, Liver Cirrhosis
Interventions: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Distal Splenorenal Shunt; Procedure
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2003
U.S. locations: 5
States / cities: Miami, Florida • Atlanta, Georgia • Cleveland, Ohio + 2 more

Conditions: Esophageal Varices
Interventions: PillCam Eso; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 318 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 3
States / cities: Scottsdale, Arizona • Plymouth, Minnesota • Portland, Oregon

Conditions: Gastric Varices
Interventions: DermaBond treatment of Gastric Varices; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Variceal Bleeding
Interventions: Endoscopic Variceal Ligation; Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Esophageal Varices, Liver Cirrhoses, Bleeding Esophageal Varices, Upper Gastrointestinal Bleeding
Interventions: Octreotide; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 8
States / cities: Jacksonville, Florida • Chicago, Illinois • Columbus, Ohio + 5 more

Conditions: Portopulmonary Hypertension
Interventions: Ambrisentan; Drug
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 6
States / cities: La Jolla, California • Jacksonville, Florida • Boston, Massachusetts + 3 more

Conditions: Esophageal and Gastric Varices
Interventions: Esophageal Capsule Endoscopy, Upper Gastrointestinal Endoscopy; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis
Interventions: belapectin, Placebo; Drug
Lead sponsor: Galectin Therapeutics Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 357 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 81
States / cities: Birmingham, Alabama • Dothan, Alabama • Chandler, Arizona + 69 more

Conditions: Gastric Varices
Interventions: Non-selective beta blockers, Retrograde transvenous obliteration; Drug · Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Gastric Varices Bleeding, Cirrhosis
Interventions: EUS-guided Coil and Cyanoacrylate Glue Injection, Endoscopic Cyanoacrylate Glue Injection; Procedure
Lead sponsor: Medanta, The Medicity, India; Other
Eligibility: 19 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Arteriovenous Malformation, Gastrointestinal Bleed, Gastric Varices, Hemorrhoid, Pelvic Venous Disorders, Peripheral Aneurysms, Portal Vein Embolization, Type II Endoleak, Varicocele, Hemorrhage
Interventions: Concerto Versa™ Detachable Coils; Device
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 22 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Piscataway, New Jersey • New York, New York • El Paso, Texas

Conditions: Gastric Varices Bleeding
Interventions: Endoscopic Ultrasound (EUS) administration of cyanoacrylate tissue adhesive to control bleeding gastric varices; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Esophageal Varices, Portal Hypertension, Gastric Varices, Esophageal Bleeding
Interventions: Sanvar® (vapreotide); Drug
Lead sponsor: Debiovision; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 19
States / cities: Birmingham, Alabama • Montgomery, Alabama • Scottsdale, Arizona + 15 more

Conditions: Esophageal and Gastric Varices, Liver Cirrhosis, Portal Hypertension
Interventions: Timolol Maleate, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2002
U.S. locations: 3
States / cities: New Haven, Connecticut • West Haven, Connecticut • Boston, Massachusetts

Conditions: Esophageal Varices
Interventions: endoscopic variceal band ligation; Procedure
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Esophageal Varices
Interventions: Capsule endoscopy, Esophagogastroduodenoscopy; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 85 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Gastric Bleeding, Cirrhosis
Interventions: Portacaval shunt, Sclerotherapy; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: Not listed
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1977 – 2003
U.S. locations: 1
States / cities: San Diego, California

Conditions: Portal Hypertension Related to Cirrhosis
Interventions: Carvedilol, Variceal band ligation; Drug · Procedure
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Cirrhosis, Liver, Hypertension, Portal, Esophageal and Gastric Varices, Bleeding Gastric, Encephalopathy
Interventions: TIPS-obliteration; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Decompression Intervention of Variceal Rebleeding Trial (DIVERT)

"Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices

Dermabond Treatment for Gastric Variceal Bleeding

Time Interval for Endoscopic Variceal Ligation

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial

Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial

EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in Cirrhosis

Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

Impact of EUS Guided Treatment of Gastric Varices

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

Prevention of Esophageal Varices by Beta-Adrenergic Blockers

Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding

Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices

Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices

Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding

TIPS Plus Transvenous Obliteration for Gastric Varices